Management of the patient with Myxomatous mitral valve degeneration (MMVD)

Loading

Management of the patient with Myxomatous mitral valve degeneration (MMVD)

18 Nov 2022
RVC Nursing Theatre

It is estimated that chronic valvular heart disease is the most common heart disease in dogs in most parts of the world. It is therefore likely that many of the patients you have registered suffer from this degenerative disease. Having a full understanding of the disease process helps the nurse explain the condition to the clients as well as supporting the patient through the phases of the disease. Medical management has always been the only treatment option but now there are surgical solutions that may be suitable for some patients. This lecture will discuss the terminology used with staging canine mitral valve disease, the current medical treatment options and how as a nurse this guides the care for your patient, and some surgical interventions that are now a real possibility.

  • Identify the needs of the patients with MMVD
  • Understand the nursing considerations for these patients with medical management
  • Understand the surgical options available for the treatment of degenerative mitral valve disease and identify patients that surgery may now be an option for
  • Understand the aims of the surgery and the post-operative needs of the patient
  • Evaluate and develop the nurse’s role within the team
Speakers
Alison Young, Clinical Operations Manager - Queen Mother Hospital for Animals

Sponsors & Partners

Education Partners

  • RVC
  • BVA

Platinum Sponsors

  • Elanco
  • Hills
  • humm
  • Idexx
  • IVC
  • Vets4Pets
  • Virbac
  • Zoetis

Gold Sponsor

  • Pioneer

Silver Sponsors

  • Medivet
  • MWI
  • GreenCross
  • iM3
  • Petsapp
  • Lintbells

Wet Lab Partner

  • Central CPD

Media Partners

  • Vet Record
  • Vet Times
  • InPractice
  • Vet Nurse Times
  • VetFile
  • Vettimes.co.uk
  • Vet Times Jobs
  • VBJ
  • VetSurgeon

BE THE LEADER OF YOUR PACK

Be the first to hear the latest news, programme updates and exclusive industry releases.